Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice.
Genetically modified CD8+ T lymphocytes have shown significant anti-tumor effects in the adoptive immunotherapy of cancer, with recent studies highlighting a potential role for a combination of other immune subsets to enhance these results. However, limitations in present genetic modification techni...
Main Authors: | Carmen S M Yong, Jennifer A Westwood, Jan Schröder, Anthony T Papenfuss, Bianca von Scheidt, Maria Moeller, Christel Devaud, Phillip K Darcy, Michael H Kershaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4624721?pdf=render |
Similar Items
-
Engineering T cell function using chimeric antigen receptors identified using a DNA library approach.
by: Connie P M Duong, et al.
Published: (2013-01-01) -
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
by: Michael H Kershaw, et al.
Published: (2021-05-01) -
Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
by: Jack D Chan, et al.
Published: (2020-01-01) -
Switching on the green light for chimeric antigen receptor T‐cell therapy
by: Sherly Mardiana, et al.
Published: (2019-01-01) -
Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping.
by: Takeshi Egawa, et al.
Published: (2008-01-01)